缺铁性贫血治疗市场，依药物类型、剂型、配销通路、地理位置

预计2024年全球缺铁性贫血治疗市值为121亿美元，预计2031年将达216亿美元，2024年至2031年年复合成长率（CAGR）为8.6%。

图 1. 2024 年缺铁性贫血治疗市占率 (%)（按地区）

据世界卫生组织称，缺铁性贫血是一种非常常见的营养缺乏症，影响全球超过十亿人。当身体没有足够的铁来产生血红蛋白时，就会发生这种情况，血红蛋白是红血球中的一种必需蛋白质，可将氧气输送到全身。症状各不相同，从疲劳、虚弱到头痛、头晕和呼吸困难。如果不及时治疗，它可能会成为一种严重的健康状况，并对身体和认知发展产生负面影响，尤其是婴儿、幼儿和妇女。随着副作用更小、疗效更高的新型口服和注射药物的出现，全球缺铁性贫血治疗市场正在强劲成长。

市场动态：

全球缺铁性贫血治疗市场的成长是由全球缺铁性贫血盛行率不断上升所推动的，特别是在儿童和妇女中。导致缺铁性贫血病例增加的关键因素包括饮食中富含铁的食物摄取不足、月经期间失血和寄生虫感染。据世界卫生组织称，全球约 40% 的孕妇患有贫血，预计将推动对有效治疗药物的需求。领先企业开发新药是该领域的重大成长机会。然而，在发展中经济体中，替代治疗方案（包括补充剂和植物疗法）的可用性可能会在不久的将来在一定程度上抑制现代药物的商业应用。

研究的主要特点：

• 该报告对全球缺铁性贫血治疗市场进行了深入分析，并提供了以2023年为基准年的预测期（2024-2031年）的市场规模和年复合成长率（CAGR%）。
• 它阐明了不同细分市场的潜在收入机会，并解释了该市场有吸引力的投资主张矩阵。
• 这项研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采取的竞争策略的重要见解。
• 它根据以下参数介绍了全球缺铁性贫血治疗市场的主要参与者——公司亮点、产品组合、主要亮点、财务表现和策略。
• 该报告的见解将使行销人员和公司管理当局能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 全球缺铁性贫血治疗市场迎合了该行业的各个利益相关者，包括投资者、供应商、产品製造商、分销商、新进业者和金融分析师。
• 利害关係人可以透过用于分析全球缺铁性贫血治疗市场的各种策略矩阵轻鬆做出决策。

目录

第一章：研究目标与假设

• 研究目标
• 假设
• 缩写

第 2 章：市场范围

• 报告说明
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map (COM)

第 3 章：市场动态、法规与趋势分析

• 市场动态
  • 司机
  • 限制
  • 市场机会
• 影响分析
• 市场走向
• 最近的发展
• 收购和合作场景
• 报销场景
• 监管场景
• 定价分析
• 品牌分析
• PEST分析

第 4 章：全球缺铁性贫血治疗市场 - 冠状病毒 (COVID-19) 大流行的影响

• 整体影响
• 政府倡议
• COVID-19 对市场的影响

第 5 章：全球缺铁性贫血治疗市场，依药物类型，2019 - 2031

• 概述
• 硫酸亚铁
• 葡萄糖酸亚铁
• 富马酸亚铁
• 氢氧化铁
• 其他的

第 6 章：全球缺铁性贫血治疗市场，按剂型，2019 - 2031 年

• 概述
• 平板电脑
• 胶囊
• 液体
• 其他的

第 7 章：全球缺铁性贫血治疗市场，依配销通路划分，2019 年 - 2031 年

• 概述
• 医院药房
• 零售药局
• 网路药局

第 8 章：全球缺铁性贫血治疗市场，按地区划分，2019 - 2031

• 介绍
• 北美洲
• 我们
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 拉丁美洲其他地区
• 欧洲
• 英国
• 德国
• 义大利
• 法国
• 西班牙
• 俄罗斯
• 欧洲其他地区
• 亚太地区
• 中国
• 印度
• 日本
• 东协
• 澳洲
• 韩国
• 亚太地区其他地区
• 中东
• 海湾合作委员会
• 以色列
• 中东其他地区
• 非洲
• 北非
• 中非
• 南非

第 9 章：竞争格局

• 公司简介
  • AdvaCare Pharma
  • Otsuka Pharmaceutical Co., Ltd.
  • Sanofi
  • Emcure Pharmaceuticals
  • Wellona Pharma
  • SiNi Pharma Pvt Ltd
  • Sun Pharmaceutical Industries Ltd.
  • Zydus Group
  • Akebia Therapeutics.
  • Rockwell Medical, Inc.
  • AbbVie Inc.
  • Pfizer, Inc.
  • Velnex Medicare
  • PHAEDRUS LIFE SCIENCE PVT. LTD.
  • Inopha International Co, Limited
  • PharmaNutra SpA
  • Pharmascience Inc.
  • American Regent, Inc.

第 10 章：分析师建议

• 命运之轮
• 分析师观点
• 连贯的机会图

第 11 章：参考文献与研究方法

• 参考
• 研究方法论

Global iron deficiency anemia treatment market is estimated to be valued at US$ 12.1 Bn in 2024 and is expected to reach US$ 21.6 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.6% from 2024 to 2031.

Figure 1. Iron Deficiency Anemia Treatment Market Share (%), By Region, 2024

Iron deficiency anemia is a very common nutritional deficiency that affects over a billion people worldwide, according to the World Health Organization. It occurs when the body does not have enough iron to produce hemoglobin, an essential protein in red blood cells that carries oxygen throughout the body. Symptoms can vary from fatigue and weakness to headaches, dizziness, and breathlessness. Left untreated, it can be a serious health condition and negatively impact physical and cognitive development especially in infants, young children and women. Global iron deficiency anemia treatment market is witnessing strong growth with emergence of new oral and injectable drugs having less side effects and higher efficacy.

Market Dynamics:

Global iron deficiency anemia treatment market growth is driven by growing prevalence of the condition globally especially among children and women. Key factors contributing to rising cases of iron deficiency anemia include poor dietary intake of iron-rich foods, blood loss during menstruation, and parasitic infections. According to WHO, approximately 40% of pregnant women worldwide suffer from anemia, which is expected to propel demand for effective therapeutic drugs. Development of novel drugs by leading players is a significant growth opportunity in this space. However, availability of alternative treatment options including supplements and plant-based remedies in developing economies can restrain commercial uptake of modern medications to some extent in the near future.

Key Features of the Study:

• This report provides in-depth analysis of the global iron deficiency anemia treatment market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global iron deficiency anemia treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study includes AdvaCare Pharma, Otsuka Pharmaceutical Co., Ltd., Sanofi, Emcure Pharmaceuticals, Wellona Pharma, SiNi Pharma Pvt Ltd, Sun Pharmaceutical Industries Ltd., Zydus Group, Akebia Therapeutics., Rockwell Medical, Inc., AbbVie Inc., Pfizer, Inc., Velnex Medicare, PHAEDRUS LIFE SCIENCE PVT. LTD., Inopha International Co, Limited, PharmaNutra S.p.A., Pharmascience Inc., and American Regent, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global iron deficiency anemia treatment market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global iron deficiency anemia treatment market

Detailed Segmentation-

• Drug Type:
  • Ferrous Sulfate
  • Ferrous Gluconate
  • Ferrous Fumerate
  • Ferric Hydroxide
  • Others
• Dosage Form:
  • Tablets
  • Capsules
  • Liquid
  • Others
• Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • AdvaCare Pharma
  • Otsuka Pharmaceutical Co., Ltd.
  • Sanofi
  • Emcure Pharmaceuticals
  • Wellona Pharma
  • SiNi Pharma Pvt Ltd
  • Sun Pharmaceutical Industries Ltd.
  • Zydus Group
  • Akebia Therapeutics.
  • Rockwell Medical, Inc.
  • AbbVie Inc.
  • Pfizer, Inc.
  • Velnex Medicare
  • PHAEDRUS LIFE SCIENCE PVT. LTD.
  • Inopha International Co, Limited
  • PharmaNutra S.p.A.
  • Pharmascience Inc.
  • American Regent, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Drug Type
  • Market Snapshot, By Dosage Form
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Recent Developments
• Acquisitions and Partnerships Scenario
• Reimbursement scenario
• Regulatory Scenario
• Pricing Analysis
• Brand Analysis
• PEST Analysis

4. Global Iron Deficiency Anemia Treatment Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the market

5. Global Iron Deficiency Anemia Treatment Market, By Drug Type, 2019 - 2031, (US$ Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Ferrous Sulfate
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
• Ferrous Gluconate
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
• Ferrous Fumerate
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
• Ferric Hydroxide
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)

6. Global Iron Deficiency Anemia Treatment Market, By Dosage Form, 2019 - 2031, (US$ Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Tablets
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
• Capsules
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
• Liquid
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)

7. Global Iron Deficiency Anemia Treatment Market, By Distribution Channel, 2019 - 2031, (US$ Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
• Online Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)

8. Global Iron Deficiency Anemia Treatment Market, By Region, 2019 - 2031, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2031
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Bn)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Bn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Bn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Bn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Bn)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (US$ Bn)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Company Profiles
  • AdvaCare Pharma *
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
  • Otsuka Pharmaceutical Co., Ltd.
  • Sanofi
  • Emcure Pharmaceuticals
  • Wellona Pharma
  • SiNi Pharma Pvt Ltd
  • Sun Pharmaceutical Industries Ltd.
  • Zydus Group
  • Akebia Therapeutics.
  • Rockwell Medical, Inc.
  • AbbVie Inc.
  • Pfizer, Inc.
  • Velnex Medicare
  • PHAEDRUS LIFE SCIENCE PVT. LTD.
  • Inopha International Co, Limited
  • PharmaNutra S.p.A.
  • Pharmascience Inc.
  • American Regent, Inc.

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact